Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Clinical trial NCT01379209 · COMPLETED

Trial details

NCT number: NCT01379209
Sponsor: Regimmune Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease

Start date: 2011-09-01
Primary completion: 2015-06-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.